This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hk Inno.n Corporation. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Ye-Lim Lee: Innovator in Protein Kinase Inhibition
Introduction
Ye-Lim Lee is a notable inventor based in Gyeongsangnam, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit protein kinases. His work is crucial in addressing various diseases, including cancer and autoimmune disorders.
Latest Patents
Ye-Lim Lee holds a patent for a heterocyclic compound that acts as a protein kinase inhibitor. This invention provides a novel compound with protein kinase inhibition activity, along with its stereoisomers and pharmaceutically acceptable salts. The compounds developed by Lee are effective in preventing or treating diseases related to protein kinases, such as cancer, autoimmune diseases, neurological disorders, and metabolic diseases.
Career Highlights
Lee is associated with Hk Inno.n Corporation, where he continues to advance his research and development efforts. His innovative approach has led to the creation of valuable therapeutic options that can significantly impact patient care.
Collaborations
Some of his notable coworkers include Hyuk Woo Lee and Mi Kyung Ji, who contribute to the collaborative efforts in research and development at Hk Inno.n Corporation.
Conclusion
Ye-Lim Lee's work in developing protein kinase inhibitors showcases his commitment to innovation in the medical field. His contributions are paving the way for new treatments that can improve the lives of many individuals suffering from serious health conditions.